CeRePP

CeRePP (Centre de Recherche sur les Pathologies Prostatiques) is a specialized research organization and clinical entity focused on the study and treatment of prostate diseases, particularly prostate cancer. Based in Paris, the organization operates as a bridge between academic research and clinical application, maintaining one of the largest biobanks of prostate tissue and fluids in Europe. CeRePP is heavily involved in the development of prognostic biomarkers and the evaluation of new therapeutic strategies, including personalized medicine approaches for urological oncology. Their work encompasses genetic susceptibility studies, clinical trials, and the validation of diagnostic tools to improve patient outcomes in urology.